Antiproliferative agent-34 is a multi-target kinase inhibitor used for inhibiting the proliferation of cancer cells, particularly under both normoxic and hypoxic conditions; it exhibits potent antiproliferative activity against H1975 and HCC827 cell lines, with IC50 values below 40 nM under normoxia and enhanced efficacy (4- to 6-fold increase, IC50 < 10 nM) under hypoxia; it targets mutant and wild-type EGFR (EGFR L858R/T790M and EGFR WT), as well as JAK2, ROS1, FLT3, FLT4, and PDGFRα kinases.